Colgate-Palmolive Company (VIE:COLG)
Austria
· Delayed Price · Currency is EUR | Market Cap | 67.25B |
| Revenue (ttm) | 17.36B |
| Net Income (ttm) | 1.82B |
| Shares Out | n/a |
| EPS (ttm) | 2.24 |
| PE Ratio | 37.04 |
| Forward PE | 25.57 |
| Dividend | 1.80 (2.17%) |
| Ex-Dividend Date | Jan 21, 2026 |
| Volume | n/a |
| Average Volume | 3 |
| Open | 82.24 |
| Previous Close | 82.10 |
| Day's Range | 82.24 - 82.73 |
| 52-Week Range | 65.20 - 91.84 |
| Beta | n/a |
| RSI | 66.89 |
| Earnings Date | Jan 30, 2026 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2025, Colgate-Palmolive Company's revenue was $20.38 billion, an increase of 1.40% compared to the previous year's $20.10 billion. Earnings were $2.13 billion, a decrease of -26.20%.
Financial numbers in USD Financial StatementsNews
Colgate-Palmolive Among 10 Companies To Announce Dividend Increases In March
Colgate-Palmolive (CL) is set to announce its 63rd consecutive annual dividend increase, with a predicted 2.9–4.8% boost to an annualized $2.14–$2.18. CL's recent restructuring has driven double-digit...
Colgate-Palmolive Webcasts Fireside Chat at the UBS Global Consumer and Retail Conference 2026
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Investor Relations Officer and EVP, M&A, John Faucher, will participate in a fireside chat at the UBS Global Consumer and Retail Conference...
Colgate-Palmolive Company (CL) Presents at Consumer Analyst Group of New York Conference 2026 Transcript
Colgate-Palmolive Company (CL) Presents at Consumer Analyst Group of New York Conference 2026 Transcript
Colgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, and SVP, Global Growth and Innovation, Hill's Pet Nutrition, Caroline Chulick, will present on Friday,...
Colgate-Palmolive: A Much-Needed Shelter For Returns In 2026
Colgate-Palmolive's high returns in recent months are a direct result of the extremely negative investor sentiment in 2025. Although the stock now trades much closer to its fair value, margin improvem...
Colgate-Palmolive: Still A Buy As The 2030 Growth Strategy Begins
Colgate-Palmolive remains a Buy as it enters its next 5-year plan, leveraging strong brands and resilient financials. Q4 earnings beat expectations, with record cash flow from operations and robust pe...
Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results
Colgate-Palmolive Company (NYSE: CL) posted better-than-expected fourth-quarter earnings on Friday.
Colgate-Palmolive Company (CL) Q4 2025 Earnings Call Transcript
Colgate-Palmolive Company (CL) Q4 2025 Earnings Call Transcript
Colgate Stock Jumps After Earnings. Why the Shares Can Keep Investors Smiling.
Colgate-Palmolive stock was up on the back of strong quarterly earnings.
Colgate-Palmolive Swings to a Loss on Charges
Colgate-Palmolive swung to a loss in the fourth quarter, hurt by a large charge tied to its struggling skin-health business, but sales climbed despite what the company says is a difficult environment.
Colgate-Palmolive forecasts upbeat annual sales as essentials spending holds firm
Toothpaste maker Colgate-Palmolive forecast annual sales above Wall Street estimates on Friday, benefiting from steady demand for essential household staples in markets such as Latin America and Europ...
Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Full Year Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS dec...
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Colgate-Palmolive Company (NYSE: CL) will release earnings results for its second quarter, before the opening bell on Friday, Jan. 30.
Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health
NEW YORK--(BUSINESS WIRE)-- #ColgatePalmolive--Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization's work on oral health....
Colgate-Palmolive Webcasts 2025 Fourth Quarter & Full Year Earnings Conference Call January 30, 2026 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. E...
This Consumer-Products Giant's Stock Is a Wall Street Top Pick for 2026
Morgan Stanley analysts named a consumer products giant known for its toothpaste one of their top picks for the year.
Calls of the Day: Disney, Colgate-Palmolive, First Solar, Toll Brothers, D.R. Horton and Amphenol
The Investment Committee debate the latest Calls of the Day.
Colgate-Palmolive: The Pullback Makes This Dividend King More Attractive
Colgate-Palmolive is rated a Buy, trading at an attractive valuation after a 30% pullback from its peak, supported by strong brands, resilient financials, and Dividend King status. CL maintains robust...
My Dividend Stock Portfolio: New November Dividend Record - 100 Holdings With 12 Buys
I trimmed positions in NVDA and AMD due to valuation concerns and overexposure, favoring BDCs like ARCC, OBDC, and HTGC for yield. November dividend income reached a record $653, up 5% Y/Y, with BDCs ...
Colgate-Palmolive: Consistent Long-Term Execution Makes It Attractive
Colgate-Palmolive (CL) is a Dividend King with strong dividend safety, high margins, and consistent long-term execution, currently trading at a reasonable 21.6x earnings. CL's science-based innovation...
